From February 6, 2024 to March 31, 2024, the company has repurchased 99,900 shares, representing 0.02% for CNY 2.94 million. With this, the company has completed the repurchase of 99,900 shares, representing 0.02% for CNY 2.94 million under the buyback announced on February 7, 2024.
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
34.15 CNY | -0.90% | -5.53% | -2.43% |
May. 07 | China Shares Rise as Property Market Gets Relief; BrightGene Jumps 7% | MT |
May. 07 | BrightGene to Sell 500 Million Yuan Shares to Actual Controller; Shares Up 3% | MT |
Annual profits - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
-2.43% | 2B | |
+51.99% | 803B | |
-5.72% | 351B | |
+18.94% | 324B | |
+11.07% | 303B | |
+16.96% | 243B | |
+2.25% | 228B | |
+11.15% | 217B | |
+7.59% | 164B | |
-3.65% | 155B |
- Stock Market
- Equities
- 688166 Stock
- News BrightGene Bio-Medical Technology Co., Ltd.
- Tranche Update on BrightGene Bio-Medical Technology Co., Ltd.'s Equity Buyback Plan announced on February 7, 2024.